VivoSeq
Other

Pancreatic

0

Pipeline Programs↗

13

Active Trials↗

3

Companies Involved↗

Pancreatic is an early-stage landscape with 0 programs across 3 companies. The most active players are Ipsen, QualiMed Innovative Medizinprodukte GmbH, Christopher C. Thompson, MD, MSc.

Intelligence

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

74/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ipsen logo

Ipsen

0 programs

PreclinicalQ

QualiMed Innovative Medizinprodukte GmbH

0 programs

PreclinicalC

Christopher C. Thompson, MD, MSc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

53

clinical trials

Completed23 · 43%
Recruiting10 · 19%
Unknown status9 · 17%
Terminated5 · 9%
Not yet recruiting2 · 4%
Suspended2 · 4%
Other2 · 4%

Clinical Trials

Trial Activity

53 trials

Reinforced Pancreaticojejunostomy With or Without glubran2
Recruiting·MMinia University·Phase 2·NCT06756074·100 enrolled
Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate
Recruiting·MMinia University·Phase 2·NCT07230509·90 enrolled
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Recruiting·AAustralasian Gastro-Intestinal Trials Group·Phase 2·NCT06345079·78 enrolled
Adjuvant Pancreatic Therapy Guided by MRD
Recruiting·RRuijin Hospital·N/A·NCT06966440·856 enrolled
Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)
Recruiting·MMinia University·Phase 1·NCT07132541·30 enrolled
Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device
Recruiting·OOrlando Health, Inc.·N/A·NCT07696572·30 enrolled
A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, POST MARKET OBSERVATIONAL STUDY TO EVALUATE THE SAFETY AND CLINICAL PERFORMANCE OF THE ARCHIMEDES BIODEGRADABLE BILIARY AND PANCREATIC STENT
Recruiting·QQualiMed Innovative Medizinprodukte GmbH·N/A·NCT04708288·198 enrolled
Evaluation of the Value of Ultrasound Measurement of Stomach Diameter in Predicting Postoperative Nausea/Vomiting
Recruiting·UUniversity Hospital, Angers·Preclinical·NCT07063069·150 enrolled
A Prospective Cohort Study on the Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer: A Comprehensive Analysis Based on Multidimensional Dynamic Psychological Assessment (MIND-PANC)
Recruiting·SShanghai Zhongshan Hospital·N/A·NCT07529626·320 enrolled
Necrosectomy With Cryotechnology for Accelerated Removal
Recruiting·CChristopher C. Thompson, MD, MSc·Preclinical·NCT06553651·20 enrolled
Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
Not yet recruiting·IIHU Strasbourg·N/A·NCT06666803·60 enrolled
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Not yet recruiting·FFudan University·Phase 1·NCT06156267·30 enrolled
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
Enrolling by invitation·AAbramson Cancer Center at Penn Medicine·N/A·NCT02471170·100 enrolled
18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants
Completed·UUniversity of Utah·Phase 1·NCT04852523·4 enrolled
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
Completed·HH. Lee Moffitt Cancer Center and Research Institute·Phase 2·NCT01581307·9 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)